News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
217 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17781)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (89)
2 (3)
3 (2)
4 (27)
5 (270)
6 (249)
7 (251)
8 (108)
9 (1)
10 (8)
11 (167)
12 (262)
13 (184)
14 (196)
15 (81)
16 (1)
17 (3)
18 (173)
19 (207)
20 (217)
21 (206)
22 (99)
23 (2)
24 (2)
25 (178)
26 (263)
27 (249)
28 (277)
29 (125)
30 (2)
31 (10)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Ionis announces enrollment completion of Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Novartis has completed patient enrollment of the pivotal Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen, with 8,325 study participants.
July 20, 2022
·
6 min read
Genetown
Karyopharm Granted Regulatory Designations for Eltanexor for the Treatment of Myelodysplastic Syndromes
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced new regulatory designations for eltanexor.
July 20, 2022
·
8 min read
Culture Media Market: North America to Dominate the Global market
Culture media is utilized in microbiological research centers to develop and control organisms.
July 20, 2022
·
6 min read
Artificial Intelligence in Ultrasound Imaging Market, 2031 | Growth Opportunities | Drivers | Challenges | Restraints | Trends
Rise in the utilization of quantitative imaging technology in the global healthcare industry is estimated to result into increased opportunities for the sales growth in the global artificial intelligence in ultrasound imaging market during the forecast period of 2021 to 2031.
July 20, 2022
·
7 min read
Venipuncture Needles and Syringes Market, Outlook 2031 | Major Trends and Drivers
The healthcare industry research report on global venipuncture needles and syringes market offers a holistic evaluation of the current landscape of the industry.
July 20, 2022
·
7 min read
Aesthetic Laser and Energy Devices Market: Overview, Key Players & Geographical Outlook 2026
The global aesthetic laser and energy devices market is driven by an increase in the number of surgeries and rise in prevalence of skin disease.
July 20, 2022
·
6 min read
Vascular Injury Treatment Market to Reach a Value of US$ 4.8 bn by 2027: TMR
The most challenging vascular injuries involve trauma caused to the abdomen, pelvis, and retroperitoneal structures of the body.
July 20, 2022
·
5 min read
Pharma 4.0 Market: Sales Projection and Current Trends| Global Industry Analysis, 2031
The research report on global pharma 4.0 market sheds light on various core trends and drivers that are expected to fast track the growth of the industry in coming years.
July 20, 2022
·
7 min read
Demand For Next Generation Patient Monitoring Devices Is Expected To Increase At A Robust CAGR Of 8.9% From 2022 To 2032
Fact.MR, a market research and competitive intelligence provider: Demand for next generation patient monitoring devices is expected to rise at a healthy CAGR of 8.9% from 2022 to 2032.
July 20, 2022
·
7 min read
Mental Disorder Drugs Market is set to See Impressive Growth to 2031, Says TMR
Wilmington, Delaware, United States, Transparency Market Research Inc.: The growing stress levels due to hectic work schedules and lifestyle changes is leading to several mental health disorders among a large chunk of individuals.
July 20, 2022
·
5 min read
Previous
9 of 22
Next